<DOC>
	<DOCNO>NCT00550095</DOCNO>
	<brief_summary>This study design assess efficacy different dosage form Valsartan [ 80 , 160 , 320 mg ] reduce microalbuminuria/proteinuria hypertensive patient type 2 diabetes .</brief_summary>
	<brief_title>To Assess Effects Valsartan Albuminuria/Proteinuria Hypertensive Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Males female age 35 75 . Type 2 diabetes mellitus ( DM ) patient couple hypertension [ sit systolic blood pressure ( SSBP ) 140179 mm Hg and/or SDBP 90109 mm Hg ] . Urinary albumin creatinine Ratio ( UACR ) ) indicate microalbuminuria/proteinuria [ 301000 mg/g 2.525 mg/mmol ] Body mass index ( BMI ) &lt; 40 kg/m2 Patients sign inform consent . Exclusion Criteria Type 1 DM All cause secondary diabetes mellitus Women childbearing potential refuse use contraception . Pregnant lactating female . Severe hypertension [ SSBP &gt; 180 mmHg , sit diastolic blood pressure ( SDBP ) &gt; 110 mmHg ] Patients combo therapy control BP Patients already Valsartan . Hypersensitivity Valsartan . Renal artery stenosis [ unilateral bilateral ] Patients take Î² blocker , ( Angiotensin Converting Enzyme Inhibitor ( ACEI ) spironolactone Heart Failure History myocardial infarction , Percutaneous Transluminal Coronary Angioplasty ( PTCA ) cerebrovascular accident within precede 3 month . Creatinine level &gt; 1.4 mg/dl [ 0.07mmol/l ] . Liver enzymes &gt; 2 time Upper Limit Normal Range ( ULN ) . Diabetic ketoacidosis ( DKA ) within last 6 month . Presence diabetic neuropathy retinopathy . Diabetic foot complication . Presence infection time screen . Hyperkalemia ( serum K+ &gt; 5.5 mmol/L )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Microalbuminuria/proteinuria</keyword>
	<keyword>hypertensive patient type 2 diabetes</keyword>
	<keyword>Valsartan</keyword>
	<keyword>microalbuminuria/proteinuria hypertensive patient type 2 diabetes</keyword>
</DOC>